Fukuyama-type congenital muscular dystrophy (FCMD), one of the most common autosomal-recessive disorders in Japan, is characterized by congenital muscular dystrophy associated with brain malformation due to a defect during neuronal migration. Through positional cloning, we previously identified the gene for FCMD, which encodes the fukutin protein. Here we report that chimeric mice generated using embryonic stem cells targeted for both fukutin alleles develop severe muscular dystrophy, with the selective deficiency of a-dystroglycan and its laminin-binding activity. In addition, these mice showed laminar disorganization of the cortical structures in the brain with impaired laminin assembly, focal interhemispheric fusion, and hippocampal and cerebellar dysgenesis. Further, chimeric mice showed anomaly of the lens, loss of laminar structure in the retina, and retinal detachment. These results indicate that fukutin is necessary for the maintenance of muscle integrity, cortical histiogenesis, and normal ocular development and suggest the functional linkage between fukutin and a-dystroglycan.
INTRODUCTION
Since the discovery of the Duchenne muscular dystrophy (DMD) gene product dystrophin (1) , many studies have focused on understanding the pathophysiology of muscular dystrophies and on developing therapeutic approaches. Structural defects in the dystrophin-glycoprotein complex (DGC) can result in a loss of linkage between laminin-2 (merosin) in the extracellular matrix and actin in the subsarcolemmal cytoskeleton, and this can lead to various muscular dystrophies (2) . Of these, a-dystroglycan is a heavily glycosylated mucin-type glycoprotein on the surface of muscle cells (3) (4) (5) . It is the key component of the DGC, providing a tight linkage between the cell and basement membranes by binding laminin via its carbohydrate residues (3) (4) (5) . a-Dystroglycan plays an active role in the basement membrane assembly itself (6) .
Fukuyama-type congenital muscular dystrophy (FCMD), one of the most common autosomal-recessive disorders in Japan, is characterized by congenital muscular dystrophy associated with brain malformation (polymicrogyria) due to a defect during neuronal migration (7) . Patients with FCMD manifest *To whom correspondence should be addressed. Tel: þ81 668793380; Fax: þ81 668793389; Email: toda@clgene.med.osaka-u.ac.jp weakness of facial and limb muscles, and general hypotonia which usually appears before 9 months of age. Functional disability is more severe in FCMD patients than in DMD patients; usually the maximum level of motor function achieved is sliding while sitting on the buttocks, and most FCMD patients are never able to walk. Patients usually become bedridden before 10 years of age due to generalized muscle atrophy and joint contracture, and most of them die by 20 years of age. Another manifestation observed in all cases is severe mental retardation; IQ scores in most FCMD patients lie between 30 and 50. Seizures occur in nearly half of the cases, in association with abnormal electroencephalograms (7) .
Through positional cloning, we previously identified the gene responsible for FCMD, which encodes the fukutin protein (8) (9) (10) . Most FCMD patients carry an ancestral mutation (11) , which arose as a consequence of the integration of a 3 kb retrotransposon element into the 3 0 untranslated region of the fukutin gene (10) . FCMD is the first known human disease to be caused by an ancient retrotransposal integration. No FCMD patients have been identified with non-founder (point) mutations on both alleles, suggesting that such patients are embryonic-lethal and that fukutin is essential for normal development (12) . There are no reported naturally occurring mice carrying mutations in the fukutin gene. Targeted homozygous mutation of this gene in mice leads to lethality at embryonic day 6.5-7.5, prior to development of skeletal muscle, cardiac muscle or mature neurons, suggesting that fukutin is essential for early embryonic development Contribution of fukutin-disrupted ES cells to brain and skeletal muscle. 129/SvEv and C57BL/6J mouse strains from which the fukutin-disrupted and wild-type tissues were derived have distinct electrophoretic variants of the two subunits of the glucose phosphate isomerase (129/SvEv, Gpi-1a; C57BL/6J, Gpi-1b). In correspondence with the coat color of the chimeric mice, the contribution of fukutin-deficient cells was high (lanes 1-3), medium (lanes 4 and 5), and low (lanes 6 and 7). (D) Survival rate of chimeric mice. The number of mice examined is shown in parentheses. . (E and F) Hanging wire grip test (E) and Rotor-rod test (F). In both tests, the chimeric mice with coat colors indicating a high contribution of fukutin-deficient cells (high) fell with a shorter latency than either wild-type mice or chimeric mice with a lower contribution of fukutin-deficient cells (medium and low). The number of mice examined is shown in parentheses. *P < 0.05.
(Kurahashi et al., unpublished data). To test the hypothesis that fukutin is necessary for maintenance of muscle integrity or histiogenesis of cerebral and cerebellar cortices, we here generated fukutin-deficient chimeric mice using embryonic stem (ES) cells targeted for both fukutin alleles. Interestingly, they also showed anomaly of the lens, loss of laminar structure in the retina, and retinal detachment. Our results indicate that fukutin is necessary for the maintenance of muscle integrity, cortical histiogenesis and normal ocular development, and suggest functional linkage between fukutin and a-dystroglycan.
RESULTS

Generation of fukutin-deficient chimeric mice
We used targeting vectors to generate ES cells in which both fukutin alleles have been disrupted by homologous recombination. To design a targeting vector for the generation of fukutindeficient chimeric mice, we characterized a cosmid clone spanning exons 1-5 of the mouse fukutin gene (13) isolated from a 129/SvEv mouse library. The 2.3 kb KpnI-BamHI fragment containing the first coding exon (exon 2) was replaced with either a neomycin or a puromycin resistance gene (Fig. 1A) , thereby removing the coding sequence corresponding to amino acids 1-35, as well as the splicing donor and acceptor sites. Targeted fukutin gene disruption was confirmed by Southern blot analysis of genomic DNA from ES cells (Fig. 1B) .
After seven rounds of blastocyst injections, a total of 62 mice were born that were determined to be highly chimeric because of their coat color (agouti). Glucose phosphate isomerase isozyme (Gpi) assay revealed that the extent of chimerism in various tissues corresponded well with that determined by coat color (Fig. 1C) . Therefore, we classified chimeric mice into three groups depending on chimerism of coat color (high, over 70% contribution of fukutin À/À cells; medium, 70-20%; and low, under 20%). Body weight was lower in the agouti mice (highly chimeric), and some died within one month. From 12 months of age, survival rates of high and medium chimeras gradually decreased. At 21 months survival rates of high, medium and low chimeras were 48, 67 and 94%, respectively (Fig. 1D ).
Behavioral abnormalities in fukutin-deficient chimeric mice
Chimeric mice were dystrophic, although those with 50% or greater contribution from heterozygous ES cells showed no obvious phenotype, consistent with the lack of phenotype in fukutin þ/À mice (Kurahashi et al., unpublished data). Agouti mice (high) developed clasping when suspended by the tail ( Fig. 2A and B) . Analysis of hind footprints showed that they were unable to walk in a straight line and dragged their feet ( Fig. 2C and D) . Chimeras also showed muscle weakness in the hanging wire grip test (Fig. 2E ) and positional instability in the rotor-rod test (Fig. 2F ). These features first appeared at about 1 month but were not progressive. Figure 3A shows the histology of skeletal muscle in the hindlimbs of fukutin-deficient chimeric mice (high, lanes 1-3 in Fig. 1C ). Massive necrosis with phagocytosis, mononuclear cell infiltration, basophilic regenerating muscle fibers, and increase of interstitial connective tissue were present at 1 month after birth. At later stages (7-9 months), a large number of small-sized muscle fibers contained central nuclei, indicating active regeneration. A small number of muscle fibers were undergoing degeneration and phagocytosis by macrophages. Connective tissue hyperplasia and fat cell deposition were also present.
Muscular dystrophic changes in fukutin-deficient chimeric mice
a-Dystroglycan, a component of the DGC, is a heavily glycosylated mucin-type glycoprotein on the surface of muscle cells (3) (4) (5) . It is the key component of the DGC, providing a tight linkage between the cell and basement membranes by binding laminin via its carbohydrate residues (3-5). a-Dystroglycan plays an active role in the basement membrane assembly itself (6) . It was demonstrated recently that a-dystroglycan was selectively deficient in skeletal muscle from FCMD patients (14) . We thus investigated the expression of a-dystroglycan, as well as the other components of the DGC, in skeletal muscle from fukutin-deficient chimeric mice by immunohistochemistry. a-Dystroglycan was greatly reduced in the sarcolemma of most muscle fibers in chimeric mice, while the other proteins, including b-dystroglycan and laminin a2 chain, were preserved (Fig. 3B) . Interestingly, all regenerating muscle fibers were deficient in a-dystroglycan, suggesting that the fukutin deficiency did not significantly interfere with muscle fiber regeneration. Anti-fukutin antibody reacts with Golgi only in normal cell lines transfected with fukutin, not in non-transfected normal cells or normal human muscle, suggesting that the expression level of endogenous fukutin may be low (Kobayashi et al., unpublished data). As muscle fibers are multi-nucleated, in situ hybridization for the targeting vector neo r did not show complete correspondence between neo r -positive and a-dystroglycan-negative fibers, although most neo r -positive fibers were a-dystroglycan-negative (data not shown).
Immunoblot analysis confirmed the reduction of adystroglycan, especially in the antibody against the lamininbinding sugar chain of a-dystroglycan (IIH6; Fig. 3C ). In addition, laminin blot overlay analysis revealed a deficiency in the laminin-binding activity of a-dystroglycan in chimeric mice (Fig. 3C) . These results indicate that the linkage between laminin-2 and a-dystroglycan on the sarcolemma is disrupted in chimeric mice.
Brain anomalies in fukutin-deficient chimeric mice
We found markedly disorganized laminar structures in the cerebral and cerebellar cortices and hippocampus of fukutindeficient chimeric mice. In the cerebral cortex, the normal sixlayered structure was not clearly discernible ( Fig. 4A and B) . In some areas, cortical neurons had overmigrated, and the molecular layer (layer I) of the cerebral cortex had disappeared. The midline interhemispheric fissure was partially deficient, with fusion of medial surfaces of the cerebral cortex ( Fig. 4C and D). A small number of pyramidal cells in the CA3 sector of the hippocampus were not laminated, although the majority of pyramidal cells were aggregated in a compact lamina. Granule cells in the dentate gyrus were aggregated in a distorted, wavy distribution ( Fig. 4E and F) . In the cerebellum, the development of folia was defective, and the cerebellar fissure between the adjoining folia were partially fused. The granular layer was disorganized along the fusion lines of adjacent folia or at the pia matter, and Purkinje cells were sporadically malpositioned. Fusions between the caudal surface of the inferior colliculus and the rostral surface of the cerebellum were also observed ( Fig. 4G and H) .
After the injection of horseradish peroxidase (HRP) into the lumbar cord, corticospinal neurons with pyramidal somata were retrogradely labeled. While the somata of HRP-labeled corticospinal neurons were situated exclusively in layer V in the motor-sensory cortex of control mice (Fig. 4I and K) , they were not distributed in any specific zone but were scattered diffusely throughout all depths of the cortex in chimeric mice ( Fig. 4J and L) .
Immunostaining with anti-laminin antibody revealed irregular interruptions of the meningeal basement membrane and granular deposits of laminin in the disorganized cerebral cortex ( Fig. 4M and N) . The meningeal basement membrane was also deficient over the fused medial cortex along the midline interhemispheric fissure or the fused cerebellar folia along the cerebellar sulci (data not shown). In contrast, the basement membrane surrounding blood vessels in the brain parenchyma was preserved. These findings indicate that fukutin is required for the assembly and/or remodeling of the meningeal basement membrane during the developmental period of brain cortical structures.
Immunoblot analysis revealed that a-dystroglycan was greatly reduced in the cerebral surface in chimeric mice and laminin blot overlay analysis revealed a deficiency in the laminin-binding activity of a-dystroglycan in chimeric mice (Fig. 4O) . These results were similar to those in skeletal muscle and suggest that abnormal laminin-dystroglycan complex possibly cause brain anomalies in chimeric mice.
Eye anomalies in fukutin-deficient chimeric mice
Eye findings were quite remarkable. Fukutin-deficient chimeric mice showed corneal opacification with vascular infiltration (Fig. 5A and B) . Microscopic analysis revealed a number of anomalies, including anomalous formation of the eyeball and lens (Fig. 5C and D) ; loss of laminar structure of the retina and retinal detachment (Fig. 5E and F) ; extensive folding of the retina (Fig. 5G) ; and thickened cornea with granular tissue formation, adhesion of the lens and cornea, and corneal inflammation and degeneration (Fig. 5H) . Electroretinography (ERG) revealed extinction of the b-wave (Fig. 5I) .
DISCUSSION
Here we have generated chimeric mice deficient in fukutin and shown that, similar to FCMD patients, the mutant mice develop neuronal migration disorder and ocular abnormality in addition to severe muscular dystrophy. At present, the function of fukutin remains unknown, and the mechanism by which its Figure 3 . Muscular dystrophic changes in fukutin-deficient chimeric mice. (A) HE stained quadriceps muscle of chimeric mice. Massive necrosis with phagocytosis (asterisk), mononuclear cell infiltration (arrowhead), basophilic regenerating fibers (arrow), and an increase in connective tissue mass was present at 1 month of age. At the late stages of 7-9 months, a large number of small-sized fibers were found to have central nuclei (arrowhead), while a small number of fibers were undergoing active degeneration (arrow). Scale bar, 100 mm. (B) Immunohistochemical analysis of sarcolemmal proteins in quadriceps muscle from normal (wt) and chimeric mice. Lam-a2, laminin a2 chain; DG, dystroglycan; Dys, dystrophin; SG, sarcoglycan; Utr, utrophin. Selective and scattered deficiency of a-dystroglycan was observed in chimeric mice, while the other proteins were preserved. Scale bar, 100 mm. (C) Immunoblot and laminin blot overlay analyses of quadriceps muscle from the two normal (wt) and three chimeric mice. a-Dystroglycan immunoreactivity, as well as its laminin-binding activity, was greatly reduced in chimeric mice, while b-dystroglycan and laminin a2 chain were preserved. The deficiency of a-dystroglycan revealed by laminin blot overlay paralleled that revealed by monoclonal antibody IIH6C4 and was more prominent than that revealed by monoclonal antibody VIA4-1 deficiency causes defects in multiple organs has not been clarified. In this respect, it should be noted that sequence analysis predicts fukutin to be an enzyme that modifies cellsurface glycoproteins or glycolipids (15) . There are several lines of indirect but significant evidence to support this. First, it was reported that highly glycosylated a-dystroglycan was selectively deficient in the skeletal muscle of FCMD patients (14) . Second, we have reported that muscle-eye-brain disease (MEB), an autosomal-recessive disorder having skeletal muscle, eye and brain defects similar to FCMD (16) , is caused by mutations in the gene encoding the protein O-linked mannose b1, 2-N-acetylglucosaminyltransferase (POMGnT1), which cause the loss of the enzyme activity (17) . Moreover, we have found the selective deficiency of a-dystroglycan in the skeletal muscle of MEB patients (18) . Finally, defective glycosylation of a-dystroglycan has also been reported in another form of congenital muscular dystrophy, MDC1C, caused by mutations in the gene encoding the putative glycosyltransferase named FKRP (fukutin-related protein) (19) and in myd mice, an animal model of congenital muscular dystrophy, caused by the mutation in the gene encoding a putative glycosyltransferase named Large (20) , although brain and eye anomalies are not the hallmarks of MDC1C. Quite recently 20% of Walker-Warburg syndrome patients have been found to have mutations in POMT1, a putative human counterpart of yeast O-mannosyltransferase (21) . Moreover, Michele et al. (22) showed, in MEB, FCMD and myodystrophy mouse, that a-dystroglycan is expressed at the muscle membrane, but similar hypoglycosylation in the diseases directly abolishes binding activity of dystroglycan for the ligands laminin, neurexin and agrin. Together with the present results, these findings suggest that defective glycosylation of a-dystroglycan due to the primary genetic defects of glycosyltransferases may be the common denominator causing muscle cell degeneration in these diseases.
Strikingly, the deficiency of a-dystroglycan revealed by laminin blot overlay paralleled that revealed by the monoclonal antibody IIH6C4, which recognizes the laminin-binding carbohydrate residues of a-dystroglycan, and was more prominent than that revealed by the monoclonal antibody VIA4-1, which recognizes carbohydrate residues unrelated to the binding of laminin (4, 23) (Figs 3C and 4O ). It is of course possible that a-dystroglycan is still present but in a hypoglycosylated form, as was suggested to occur in FCMD by Michele et al. (22) . This raises the possibility that fukutin may be involved in the modification of laminin-binding carbohydrate residues in a-dystroglycan and, in the absence of fukutin, the linkage between laminin and a-dystroglycan may never be established on the muscle cell surface. This scenario is also consistent with the report that chimeric mice lacking skeletal muscle dystroglycan developed muscular dystrophy similar to the mice described here (24) .
Finally, the role of dystroglycan in the pathogenesis of brain and eye defects in FCMD remains unclear. Brain and/or eye defects similar to those reported here have recently been observed in mice lacking dystroglycan in the brain via Cre/ loxP-mediated gene inactivation (25) and in myd mice, although the retina was apparently morphologically normal (26) . Interestingly, brain and/or eye defects similar to those reported here have also been observed in mice lacking integrin b1 subunit in brain via Cre/loxP-mediated gene inactivation (27) and in mice carrying a targeted mutation in the integrin a6 subunit gene (28), respectively. We can envisage that the defects in dystroglycan have similar consequences as those caused by integrin deficiency, because these two receptors are thought to work in concert. Alternatively, fukutin might be involved in the modification of the carbohydrate residues of integrin subunits in brain and eye, and integrin might not function normally in the absence of fukutin, although immunostaining for integrin a7 on skeletal muscle cryosections showed no difference (data not shown).
Our data indicates that fukutin is essential for maintenance of muscle integrity, cortical histiogenesis, and normal eye development and suggest the functional linkage between fukutin and a-dystroglycan. Fukutin-deficient chimeric mice are suitable models for studying not only the biological function of fukutin but also the molecular pathogenesis of and therapeutic approaches to complex disorders exhibiting the simultaneous occurrence of central nervous, ocular and muscular abnormalities seen in FCMD and its related diseases.
MATERIALS AND METHODS
Targeted disruption of fukutin
A cosmid clone spanning exons 1-5 of the mouse fukutin gene was isolated from a 129/SvEv mouse library. Two targeting vectors were constructed with a 12 kb KpnI-BlpI fragment containing the first coding exon (exon 2) and flanking introns. The 2.3 kb KpnI-BamHI fragment containing exon 2 was replaced with either a neomycin or a puromycin resistance gene (pKO-Select Neo or pKO-Select Puro, Lexicon), thereby removing the coding sequence corresponding to amino acids 1-35, as well as the splicing donor and acceptor sites. Targeting vectors were linearized using NotI, and AB2.2 prime ES cells (Lexicon) were first electroporated with the neo r vector. We In chimeric mice, the basement membrane was interrupted (arrowhead), and laminin was deposited in sporadic granules (asterisk) in the cerebral cortex. Scale bar, 100 mm. (O) Immunoblot and laminin blot overlay analyses of cerebral surface from the three normal (wt) and four chimeric mice. a-dystroglycan immunoreactivity, as well as its laminin-binding activity, was greatly reduced in chimeric mice. The results were similar to those in skeletal muscle (Fig. 3C) . picked, expanded and screened Geneticin-resistant (Sigma) clones for homologous recombination. One clone (no. 8) was chosen and electroporated with the puro r vector. Puromycinresistant clones were screened to identify homologous recombinant clones. The double copy-targeted ES cell clone P182 was injected into E3.5 blastocysts of the C57BL/6 mouse strain using standard methods. Mice were maintained in accordance with the Animal Care guidelines of Otsuka Pharmaceutical Co. Ltd.
Evaluation of fukutin-null ES cell contribution to chimeric mice
Mice were sacrificed between 1 and 9 months of age. Protein extracts from tissue samples were subjected to Gpi electrophoresis, and the Gpi variants were stained on the cellulose acetate gels (Helena).
Behavioral phenotyping
Mice were tested during the light phase of their light-dark cycle between 13:00 and 17:00. Mice 7-9 months old were placed on the rotor-rod treadmill apparatus (rod diameter, 3 cm, MK-600, Muromachi Kikai) for a maximum of 60 s, and the latency to fall off the rod within the time period was recorded. Five consecutive trials were performed at 12 rpm. The hanging wire test was carried out by placing 5-to 7-month-old mice on top of the wire cage lid and turning the lid upside down. The latency to fall off the wire was measured up to 60 s. To record the footprint pattern, hindpaws were dipped in India ink, and mice were allowed to walk along a 35 cm long, 10 cm wide runway with 6 cm high walls. The footprints were recorded on a clean sheet of white paper placed on the floor of the dark tunnel. All mice were given one training run per week for 3 weeks before being subjected to a test run.
Histology and immunohistochemistry
Animals were anesthetized with ether and exsanguinated. Brains and eyes were removed and fixed with 10% formalin in 10 mM phosphate buffer (pH 7.2) for 4 days. After paraffin embedding, cerebrums were sectioned serially to 8 mm thickness at coronale. Cerebellums and eyeballs were sectioned to In chimeric mice, the lens had a peculiar shape, with the sclera bent and intercalated between the lens and retina (D). The laminar structure of the retina was completely disorganized and retinal detachment was present (F). The retina was misfolded extensively in a wavy pattern (arrowhead) (G). The cornea was thickened by granular tissue formation (asterisk) and adhered to the lens with inflammation (arrowhead) (H). Scale bar, C and D, 1.3 mm; E-H, 100 mm. (I) ERG revealed extinction of the b-wave.
8 mm thickness at sagittal. Every tenth section was counterstained with hematoxylin and eosin (HE) or by Klüver-Barrera's (KB) methods. Several adjoining sections were immunostained with a polyclonal anti-laminin antibody (Harber Bio-products). For skeletal muscle, serial frozen cryosections (8 mm) were stained with HE or immunostained with the monoclonal a-dystroglycan antibody VIA4-1 (Upstate) or antisera against laminin a2 chain (29), b-dystroglycan (30), dystrophin (31), a-sarcoglycan (29), b-sarcoglycan (32), and utrophin (30) . After incubation with Alexa Fluor 488-labeled secondary antibodies (Molecular Probes), sections were examined under a fluorescent microscope.
Immunoblot and laminin blot overlay SDS-PAGE, 3-12%, and immunoblotting of skeletal muscle and cerebral surface cryosections were performed as described previously (33) , using the monoclonal antibodies IIH6C4 and VIA4-1 against a-dystroglycan (Upstate), the antiserum against b-dystroglycan, and the monoclonal antibody 2D9 against the laminin a2 chain (34) . The laminin blot overlay was performed using 3 nM laminin-1 (Koken), and the laminin bound to a-dystroglycan on the polyvinylidene difluoride membrane was detected using a polyclonal anti-laminin antibody (Sigma).
HRP labeling
One microliter of 10% aqueous solution of HRP (type VI, Sigma) was injected into both sides of the upper lumbar cord. After 48 h, the animals were transcardially perfused with 1.25% glutaraldehyde and 1% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brain and spinal cord were immersed in 30% phosphate-buffered sucrose overnight at 4 C, sectioned coronally at 40 mm thickness on a freezing microtome, and reacted for the presence of HRP using the chromagen tetramethylbenzidine (TMB) (35) .
Electroretinography
Following 15 min of dark adaptation, ERGs were recorded from the corneal surface electrode after mydriasis. Stimulation with white flash light (10 J) was used (Photostimulator 3G21, NEC-Sanei).
